[TAVI in 2018 : new indications and open questions]
- PMID: 29797856
[TAVI in 2018 : new indications and open questions]
Abstract
The last years, various large randomized studies have demonstrated the benefit of TAVI (transcatheter aortic valve implantation) over medical therapy or over conventional surgical treatment in inoperable or very high risk patients with symptomatic severe aortic stenosis. More recently, new data has also shown that among patients at intermediate risk, TAVI is at least as beneficial as surgical valve replacement. In this article, we will focus on the new recommendations of the European society of cardiology but also on issues that remain open.
Ces dernières années, différentes grandes études randomisées ont démontré le bénéfice du TAVI (transcatheter aortic valve implantation) par rapport au traitement médicamenteux ou au traitement chirurgical conventionnel chez les patients avec sténose aortique sévère symptomatique inopérables ou à très haut risque. Plus récemment, de nouvelles données ont également démontré que parmi les patients à risque intermédiaire, le TAVI est au moins aussi bénéfique que le remplacement valvulaire chirurgical. Dans le présent article, nous allons nous intéresser aux nouvelles recommandations de la Société européenne de cardiologie mais également aux questions qui demeurent ouvertes.
Conflict of interest statement
Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
Similar articles
-
Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society….Kardiol Pol. 2017;75(9):937-964. doi: 10.5603/KP.2017.0175. Kardiol Pol. 2017. PMID: 28895996
-
[Interventional therapy of aortic valve stenosis in Germany].Internist (Berl). 2016 Apr;57(4):304-16. doi: 10.1007/s00108-016-0028-8. Internist (Berl). 2016. PMID: 26902868 Review. German.
-
Prognostic benefit of transcatheter aortic valve implantation compared with medical therapy in patients with inoperable aortic stenosis.Catheter Cardiovasc Interv. 2010 Jun 1;75(7):1121-6. doi: 10.1002/ccd.22418. Catheter Cardiovasc Interv. 2010. PMID: 20146205
-
Two-year mortality after transcatheter aortic valve implantation versus medical therapy for high-surgical risk or inoperable aortic stenosis patients.J Heart Valve Dis. 2013 Jan;22(1):71-8. J Heart Valve Dis. 2013. PMID: 23610992
-
The expanding indications of transcatheter aortic valve implantation.Future Cardiol. 2016 Mar;12(2):209-19. doi: 10.2217/fca.15.86. Epub 2016 Feb 26. Future Cardiol. 2016. PMID: 26916608 Review.
Cited by
-
Futility in TAVI: A scoping review of definitions, predictive criteria, and medical predictive models.PLoS One. 2025 Jan 9;20(1):e0313399. doi: 10.1371/journal.pone.0313399. eCollection 2025. PLoS One. 2025. PMID: 39787130 Free PMC article.